Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · REGISTER · 2010-09-01 · DEPARTMENT OF JUSTICE · Notices

Notices. DEPARTMENT OF JUSTICE

288 words·~1 min read·/register/2010/09/01/2010-21784

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4410-09-P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Application Pursuant to § 1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on April 15, 2010, American Radiolabeled Chemicals, Inc., 101 Arc Drive, St. Louis, Missouri 63146, made application by renewal to the Drug Enforcement Administration
(DEA)as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule Gamma Hydroxybutyric Acid
(2010)I Ibogaine
(7260)I Lysergic acid diethylamide
(7315)I Tetrahydrocannabinols
(7370)I Dimethyltryptamine
(7435)I 1-[1-(2-Thienyl)cyclohexyl]piperidine
(7470)I Dihydromorphine
(9145)I Normorphine
(9313)I Amphetamine
(1100)II Methamphetamine
(1105)II Amobarbital
(2125)II Phencyclidine
(7471)II Phenylacetone
(8501)II Cocaine
(9041)II Codeine
(9050)II Dihydrocodeine
(9120)II Oxycodone
(9143)II Hydromorphone
(9150)II Ecgonine
(9180)II Hydrocodone
(9193)II Meperidine
(9230)II Metazocine
(9240)II Dextropropoxyphene, bulk (non-dosage forms)
(9273)II Morphine
(9300)II Oripavine
(9330)II Thebaine
(9333)II Oxymorphone
(9652)II Phenazocine
(9715)II Fentanyl
(9801)II The company plans to manufacture small quantities of the listed controlled substances as radiolabeled compounds for biochemical research. Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a). Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than November 1, 2010. Dated: August 3, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 2010-21784 Filed 8-31-10; 8:45 am]
Connectionstraces to 1
Citation graph
cites case law
Notices
DEPARTMENT OF JUSTICE
C.F.R.§ 1301.33
Cites 1Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.